Results 1 to 10 of about 624,402 (215)
Frontiers in Oncology, 2022 The diagnosis of thymic carcinoma may pose significant problems not necessarily in the histopathological diagnosis but rather in assigning the thymus as specific origin.
Doaa Alqaidy, Cesar A. Moran
doaj +3 more sources
Diagnosis of Thymic Clear Cell Carcinoma by Cytology [PDF]
Case Reports in Pathology, 2013 Clear cell carcinoma of the thymus is a rare tumor. Few cases of clear-cell carcinoma of thymus have been documented (Truong et al., 1990 and Wolfe III et al., 1983).
Seema A. Lale +2 more
doaj +2 more sources
Total thymectomy for thymic lymphoepithelioma-like carcinoma—report of two cases
Surgical Case Reports, 2019 Background Thymic carcinoma has been classified into 12 subtypes, thymic lymphoepithelioma-like carcinoma (LELC) is a type of them, and has a pathological organization similar to that of lymphoepithelioma, an undifferentiated type of nasopharyngeal ...
Sachi Kawagishi +8 more
doaj +1 more source
Case Reports in Oncology, 2014 Little information is available about the usefulness of concurrent chemoradiotherapy for locally advanced thymic carcinoma due to a rare anterior mediastinal tumor.
Toshirou Fukushima +5 more
doaj +1 more source
Adjuvant Therapy for Thymic Carcinoma--A Decade of Experience in a Taiwan National Teaching Hospital. [PDF]
PLoS ONE, 2016 Thymic carcinomas are rare tumors for which surgical resection is the first treatment of choice. The role of adjuvant treatment after surgery is unknown because of limited available data.
Yen-Han Tseng +8 more
doaj +1 more source
Thoracic Cancer, 2023 Background Thymic squamous cell carcinoma and type B3 thymoma are primary neoplasms of the anterior mediastinum that are sometimes difficult to differentiate from one another histologically.
Koichiro Kanamori +19 more
doaj +1 more source
Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma
Thoracic Cancer, 2023 Thymic carcinoma is a highly malignant tumor and treatment options are limited. Lenvatinib, a novel multitargeted kinase inhibitor, has recently been approved for the treatment of unresectable thymic carcinoma.
Masatoshi Shimura +10 more
doaj +1 more source
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report
Thoracic Cancer, 2022 Advanced thymic carcinomas have limited treatment options. Recently, lenvatinib was approved for advanced thymic carcinoma treatment. However, the clinical benefit of lenvatinib re‐administration in patients with advanced thymic carcinoma who developed ...
Yuto Terashima +3 more
doaj +1 more source
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
Aging and Cancer, EarlyView.This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley +1 more source
Enteric thymic adenocarcinoma: Understanding a unique pathology in the mediastinum
Indian Journal of Pathology and MicrobiologyThymic malignancies are rare neoplasms, with thymoma and thymic carcinoma—collectively known as thymic epithelial tumors (TETs)—being uncommon tumors that originate from the thymus.
Raja Chhabra +7 more
doaj +1 more source